Stephen McAndrew

Stephen McAndrew

Geen lopende functies
72 jaar
Health Technology
Consumer Services

Profiel

Stephen J.
McAndrew
worked as Director-Biotechnology Licensing at Bristol Myers Squibb Co. from 1993 to 2001.
From 2001 to 2003, served as VP-Pharmaceutical Business Development at Lexicon Pharmaceuticals, Inc. Held the position of Vice President-Business Development at Xenogen Biosciences Corp.
between 2004 and 2007.
From 2007 to 2009, was Vice President-Business Development at Caliper Life Sciences, Inc. Served as Vice President-Scientific Commercial Development at Taconic Biosciences, Inc. from 2009 to 2011.
Was President at SJM Biopharm Consulting from 2011 to 2012.
From 2014 to 2019, held the role of Senior VP-Business Strategy & Development at Outlook Therapeutics, Inc. The education history includes undergraduate studies at State University of New York College at Oswego, graduate studies at State University of New York at Albany, and a doctorate from The Ohio University.

Eerdere bekende functies van Stephen McAndrew

BedrijvenFunctieEinde
SONNET BIOTHERAPEUTICS President 02-12-2025
OUTLOOK THERAPEUTICS, INC. Corporate Officer/Principal 01-10-2019
SJM Biopharm Consulting
President 01-02-2012
Corporate Officer/Principal 01-03-2011
Corporate Officer/Principal 01-12-2009
Ervaring van Stephen McAndrew in detail bekijken

Opleiding van Stephen McAndrew

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

70

Eerstegraads connecties

11

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit11

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

SJM Biopharm Consulting

Health Technology

  1. Beurs
  2. Insiders
  3. Stephen McAndrew
DE LAATSTE UREN | -40 %: De beste tools voorbehouden aan abonnees om de beste beleggingen van morgen te identificeren!
d
:
:
PROFITEER NU